Depressed head and neck cancer patients three-and-one-half times less likely to survive, have higher recurrence risk

Depression is a significant predictor of five-year survival and recurrence in head and neck cancer patients, according to a new study. There is also increasing evidence for modest associations between elevated symptoms of depression and increased mortality risk in lung, breast, ovarian and kidney cancer.